SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
1 federal contract opportunities classified as Cellular Therapy Products.
AI Summary
The National Institutes of Health intends to award a sole source contract to Takara Bio USA Inc. for RetroNectin® GMP grade reagents, essential for cellular therapy product manufacturing. Interested parties may submit capability statements by May 14, 2026. This opportunity is conducted under FAR Part 13, allowing for s…
MD
Common questions about finding and winning Cellular Therapy Products government contracts.